Allergan Exec Bonus Suit Should Be Axed, Judge Says

Law360, Wilmington (March 13, 2014, 10:12 PM EDT) -- A Delaware magistrate judge urged the court on Thursday toss a shareholder derivative suit claiming Allergan Inc.'s directors gave investors misleading information about a proposed executive bonus plan, saying the pharmaceutical company's motion to dismiss should be granted on “demand futility” grounds.

In a 13-page report, U.S. Magistrate Judge Sherry R. Fallon said the New Jersey Building Laborers Pension Fund lacked standing to bring a shareholder derivative suit because it did not ask the board to take action prior to filing and failed to show that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.